Use of intravenous immunoglobulin (IVIg) in addition to antiviral therapy for the treatment of CMV disease in heart transplanted patients with secondary hypogammaglobulinemia

P.Mun?oz; J.Bermejo; E.Sarmiento; J.Palomo; J.Yan?ez; E.Ferna?ndez-Cruz; J.Carbone

首页> 外文期刊>International journal of infectious diseases : >Use of intravenous immunoglobulin (IVIg) in addition to antiviral therapy for the treatment of CMV disease in heart transplanted patients with secondary hypogammaglobulinemia

【24h】

Use of intravenous immunoglobulin (IVIg) in addition to antiviral therapy for the treatment of CMV disease in heart transplanted patients with secondary hypogammaglobulinemia

机译：除抗病毒治疗外，还使用静脉注射免疫球蛋白（IVIg）治疗继发性低丙种球蛋白血症的心脏移植患者的CMV疾病

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2002年第2期|共1页
作者
P.Mun?oz; J.Bermejo; E.Sarmiento; J.Palomo; J.Yan?ez; E.Ferna?ndez-Cruz; J.Carbone;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. [J] . Sarmiento E, Fernandez Yanez J, Munoz P, International immunopharmacology . 2005,第1期

机译：心脏移植后的低血球蛋白血症：在复发性CMV疾病中使用静脉免疫球蛋白替代疗法。
2. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective? [J] . Jone Pei-Ni, Anderson Marsha S., Mulvahill Matthew J., The Pediatric infectious disease journal . 2018,第10期

机译：英夫利昔单抗加上静脉内免疫球蛋白（IVIG）与IVIG单独作为汗崎病患儿患有冠状动脉病变的初始治疗：双重治疗更有效吗？
3. Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS [J] . Imashuku Shinsaku CNS & neurological disorders drug targets . 2015,第6期

机译：静脉免疫球蛋白（IVIG）治疗与中枢神经系统朗格汉斯细胞组织细胞增生症（LCH）相关的神经退行性疾病的患者
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease [D] . Miyakoshi, Chisato 2019

机译：川崎病的心率，对静脉免疫球蛋白的反应性和冠状动脉瘤
6. Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada [O] . William C Gerth, Stephen D Betschel, Arthur S Zbrozek 2014

机译：加拿大原发性免疫缺陷（PID）和继发性免疫缺陷（SID）患者从医院静脉内免疫球蛋白（IVIg）转向家庭皮下免疫球蛋白（SCIg）治疗对付款人的影响
7. Use of intravenous immunoglobulin (IVIg) in addition to antiviral therapy for the treatment of CMV disease in heart transplanted patients with secondary hypogammaglobulinemia [O] . Muñoz P., Bermejo J., Sarmiento E., 2002

机译：除抗病毒治疗外，还使用静脉注射免疫球蛋白（IVIg）治疗继发性低血球蛋白血症的心脏移植患者的CMV疾病

Use of intravenous immunoglobulin (IVIg) in addition to antiviral therapy for the treatment of CMV disease in heart transplanted patients with secondary hypogammaglobulinemia

著录项

相似文献

相关主题

期刊订阅